EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a camelid single-domain antibody-based antigen detection assay for the pan-specific diagnosis of active human and animal Trypanosoma brucei infections

Zeng Li iD, Bo-Kyung Jin, Emily Estefania Timaury Moreno, Andrés Álvarez-Rodríguez, Jo A Van Ginderachter, Magdalena Radwanska, Yann G-J Sterckx iD, Benoit Stijlemans, Stefan Magez iD

Journal of Clinical Microbiology · 17.12.2025 · 63 (12)

DOI: 10.1128/jcm.00561-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 17.12.2025. Verfasst von Zeng Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology (BCIM), Department of Bioengineering Sciences (DBIT), Vrije Universit…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Trypanosoma brucei brucei, Antigens, Protozoan, Trypanosomiasis, African. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program, UGhent BOF funding, Strategic Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trypanosoma brucei infections cause African trypanosomiasis, also known as sleeping sickness in humans and nagana in animals, presenting a significant global health and economic burden, especially in sub-Saharan Africa. Animal trypanosomiasis also affects the economic development in Asia and South America. Accurate diagnosis of diseases caused by infection with the parasite of the T. brucei group remains a major challenge due to the persistence of infection-induced antibodies long after parasite clearance, complicating serological discrimination between active and past infections. To address this limitation, we developed a sensitive and specific antigen detection assay targeting Trypanosoma brucei enolase ( Tbr ENO) using a panel of camelid single-domain antibodies (sdAbs also known as nanobodies). Among the candidates, the sdAbsR3-77/sdAbR2-103 sandwich enzyme-linked immunosorbent assay (ELISA) exhibited robust performance in detecting circulating Tbr ENO in plasma from experimentally infected mice. Additionally, this assay showed strong potential as a “test-of-cure” tool by monitoring real-time antigenemia throughout a chronic T. brucei infection course. We further validated the assay’s diagnostic utility in human clinical samples, detecting Trypanosoma brucei rhodesiense infections at both early and advanced stages and Trypanosoma brucei gambiense infections in advanced stage. The sdAbsR3-77H/sdAbR2-103HA ELISA targeting Tbr ENO shows potential for point-of-care pan-diagnosis of active T. brucei infections (including Trypanosoma brucei brucei , T. b. gambiense , T. b. rhodesiense , Trypanosoma brucei evansi , and Trypanosoma brucei equiperdum ) in both animals and humans. Therefore, this assay addresses gaps in current diagnostic capabilities by overcoming the key limitations of antibody-based tests, offering a promising tool for improved disease control. IMPORTANCE African trypanosomiasis, commonly known as sleeping sickness in humans and nagana in animals, is a life-threatening disease that remains a major health and economic concern in many parts of the world. One of the key difficulties in managing this disease is detecting ongoing infections, as existing antibody-based tests cannot reliably distinguish between current and past infections. In this study, we developed a novel laboratory test that detects a specific protein released by the parasite during infection. This test uses special antibodies derived from camels, known for their exceptional stability and precision, to accurately identify infections caused by multiple Trypanosoma brucei subspecies. Our approach not only enables accurate diagnosis but also offers a way to monitor treatment success. This work provides a valuable tool for disease control efforts and could help improve the health of both humans and animals in regions where trypanosomiasis is endemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesTrypanosoma brucei bruceiAntigens, ProtozoanTrypanosomiasis, AfricanCamelidaePoint-of-Care TestingSensitivity and SpecificityPhosphopyruvate HydrataseRecombinant ProteinsEnzyme-Linked Immunosorbent AssayMice, Inbred C57BLDisease Models, AnimalHumansAnimalsMice

Stichwörter der Autor:innen

Trypanosoma bruceidiagnosisenolasesandwich ELISA assaysingle-domain antibody

Substanzen

Single-Domain AntibodiesAntigens, ProtozoanPhosphopyruvate HydrataseRecombinant Proteins

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology (BCIM), Department of Bioengineering Sciences (DBIT), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
  • Myeloid Cell Immunology Laboratory, VIB Center for Inflammation Research, Brussels, Belgium.
  • Laboratory for Biomedical Research, Department of Environmental Technology, Food Technology and Molecular Biotechnology, Ghent University Global Campus, Incheon, South Korea.
  • Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Laboratory of Medical Biochemistry (LMB) and the Infla-Med Centre of Excellence, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Zeng Li, Yann G-J Sterckx, Stefan Magez

Förderung

  • European Union's Horizon 2020 research and innovation program
  • UGhent BOF funding
  • Strategic Research Program
  • European Union’s Horizon 2020 research and innovation program

Zitieren

APA

Li, Z., Jin, B., Moreno, E. E. T., Álvarez-Rodríguez, A., Ginderachter, J. A. V., Radwanska, M., Sterckx, Y. G. J., Stijlemans, B., & Magez, S. (2025). Development of a camelid single-domain antibody-based antigen detection assay for the pan-specific diagnosis of active human and animal Trypanosoma brucei infections. Journal of Clinical Microbiology, 63(12). https://doi.org/10.1128/jcm.00561-25

Vancouver

Li Z, Jin B, Moreno EET, Álvarez-Rodríguez A, Ginderachter JAV, Radwanska M, et al. Development of a camelid single-domain antibody-based antigen detection assay for the pan-specific diagnosis of active human and animal Trypanosoma brucei infections. Journal of Clinical Microbiology. 2025;63(12). doi:10.1128/jcm.00561-25

BibTeX
@article{Li2025,
  author = {Li, Zeng and Jin, Bo-Kyung and Moreno, Emily Estefania Timaury and Álvarez-Rodríguez, Andrés and Ginderachter, Jo A Van and Radwanska, Magdalena and Sterckx, Yann G-J and Stijlemans, Benoit and Magez, Stefan},
  title = {Development of a camelid single-domain antibody-based antigen detection assay for the pan-specific diagnosis of active human and animal Trypanosoma brucei infections},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  volume = {63},
  number = {12},
  doi = {10.1128/jcm.00561-25}
}
Kostenlos starten →